Cancer statistics, 2014

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries and mortality data were collected by the National Center for Health Statistics. A total of 1,665,540 new cancer cases and 585,720 cancer deaths are projected to occur in the United States in 2014. During the most recent 5 years for which there are data (2006‐2010), delay‐adjusted cancer incidence rates declined slightly in men (by 0.6% per year) and were stable in women, while cancer death rates decreased by 1.8% per year in men and by 1.4% per year in women. The combined cancer death rate (deaths per 100,000 population) has been continuously declining for 2 decades, from a peak of 215.1 in 1991 to 171.8 in 2010. This 20% decline translates to the avoidance of approximately 1,340,400 cancer deaths (952,700 among men and 387,700 among women) during this time period. The magnitude of the decline in cancer death rates from 1991 to 2010 varies substantially by age, race, and sex, ranging from no decline among white women aged 80 years and older to a 55% decline among black men aged 40 years to 49 years. Notably, black men experienced the largest drop within every 10‐year age group. Further progress can be accelerated by applying existing cancer control knowledge across all segments of the population. CA Cancer J Clin 2014;64:9–29. © 2014 American Cancer Society, Inc.

[1]  Rascon [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.

[2]  P. Trott,et al.  International Classification of Diseases for Oncology , 1977 .

[3]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[4]  B A Miller,et al.  The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.

[5]  W. Weiss,et al.  Cigarette smoking and lung cancer trends. A light at the end of the tunnel? , 1997, Chest.

[6]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[7]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[8]  E. Feuer,et al.  Impact of reporting delay and reporting error on cancer incidence rates and trends. , 2002, Journal of the National Cancer Institute.

[9]  P. Walsh Survival of blacks and whites after a cancer diagnosis. , 2002, The Journal of urology.

[10]  Ahmedin Jemal,et al.  Trends in Breast Cancer by Race and Ethnicity , 2003, CA: a cancer journal for clinicians.

[11]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[12]  M. Banerjee,et al.  Race, socioeconomic status and stage at diagnosis for five common malignancies , 2003, Cancer Causes & Control.

[13]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer. , 2006, The New England journal of medicine.

[14]  D. Nerenz,et al.  Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.

[15]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[16]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[17]  M. Goodman,et al.  Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001 , 2006, Cancer.

[18]  Charles Wiggins,et al.  Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. , 2007, Cancer.

[19]  Mark Hachey,et al.  A New Method of Estimating United States and State‐level Cancer Incidence Counts for the Current Calendar Year , 2007, CA: a cancer journal for clinicians.

[20]  Dante diTommaso,et al.  Quantifying the role of PSA screening in the US prostate cancer mortality decline , 2008, Cancer Causes & Control.

[21]  O. Carrasquillo,et al.  Racial/ethnic disparities in time to follow-up after an abnormal mammogram. , 2008, Journal of women's health.

[22]  C. Gross,et al.  Racial disparities in cancer therapy , 2008, Cancer.

[23]  Xiao-Cheng Wu,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control , 2008, Journal of the National Cancer Institute.

[24]  T. Byers,et al.  The impact of socioeconomic status on survival after cancer in the United States , 2008, Cancer.

[25]  P. Rosenberg,et al.  Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. , 2009, Journal of the National Cancer Institute.

[26]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[27]  A. Jemal,et al.  Predicting US‐ and state‐level cancer counts for the current calendar year , 2012, Cancer.

[28]  Ahmedin Jemal,et al.  Cancers with increasing incidence trends in the United States: 1999 through 2008 , 2012, CA: a cancer journal for clinicians.

[29]  A. Jemal,et al.  Predicting US‐ and state‐level cancer counts for the current calendar year , 2012, Cancer.

[30]  Ahmedin Jemal,et al.  Trends in Colorectal Cancer Incidence Rates in the United States by Tumor Location and Stage, 1992–2008 , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[31]  Kevin A. Henry,et al.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.